EPIGENETIC SILENCERS. “Moreover, in 126 cases of several types of hematologic malignancies, Bmal1 gene silencing due to CpG promoter methylation was found in 19.7% of diffuse large B cell lymphomas, 33.3% of acute lymphocytic leukemias, and 19.2% of acute myeloid leukemias.”
https://www.nature.com/articles/s41591-018-0271-8?fbclid=IwAR01C2Z4J5lxVYDLhxIb9dPb3fhNSZSxwimZvhHaJ4n3-nVPpkt2PNqoukk